Evidence map›Paper›PMID 21726817›Full record

ArticleMolecular cell2011

Transcription factor AP1 potentiates chromatin accessibility and glucocorticoid receptor binding.

Simon C Biddie, Sam John, Pete J Sabo, Robert E Thurman, Thomas A Johnson, R Louis Schiltz, Tina B Miranda, Myong-Hee Sung, Saskia Trump, Stafford L Lightman and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 319 papers.

0numbers the graph read from it
0cells of the map it votes in
319citing papers in PubMed
16.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

319 citing papers in PubMed, 495 citations in OpenAlex.

  1. Trial
  2. Article
  3. AlphaGenome Atlas:medRxiv : the preprint server for health sciences · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

259 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

Simon C BiddieLaboratory of Receptor Biology and Gene Expression, B602, Building 41, 41 Library Drive, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Sam John
Pete J Sabo
Robert E Thurman
Thomas A Johnson
R Louis Schiltz
Tina B Miranda
Myong-Hee Sung
Saskia Trump
Stafford L Lightman
Charles Vinson
John A Stamatoyannopoulos
Gordon L Hager
National Institutes of Health · USUniversity of Washington · USNational Cancer Institute · USHelmholtz Centre for Environmental Research · DEUniversity of Bristol · GB

Funding

Chromatin Structure and Gene ExpressionZIABC005450 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HAGER, GORDON L · 2009 to 2025
$35.2M
In vivo Imaging Analysis of SteroidNuclear Receptor FunctionZIABC010308 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HAGER, GORDON L · 2009 to 2025
$8.4M
Digital DNaseI mapping and footprinting of the mouse genomeRC2HG005654 · NHGRI · UNIVERSITY OF WASHINGTON · PI GROUDINE, MARK T, STAMATOYANNOPOULOS, JOHN A · 2009 to 2011
$2.0M
CHROMATIN STRUCTURE AND GENE EXPRESSIONZ01BC005450 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HAGER, GORDON · 1996 to 2008
$1.7M
In vivo Imaging of Steroid/Nuclear Receptor FunctionZ01BC010308 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HAGER, GORDON · 1999 to 2008
$735k
Intramural NIH HHS Z01 BC005450Intramural NIH HHS Z01 BC010308NHGRI NIH HHS 1RC2HG005654NHGRI NIH HHS RC2 HG005654
6 · The paper itself

Abstract

Ligand-dependent transcription by the nuclear receptor glucocorticoid receptor (GR) is mediated by interactions with coregulators. The role of these interactions in determining selective binding of GR to regulatory elements remains unclear. Recent findings indicate that a large fraction of genomic GR binding coincides with chromatin that is accessible prior to hormone treatment, suggesting that receptor binding is dictated by proteins that maintain chromatin in an open state. Combining DNaseI accessibility and chromatin immunoprecipitation with high-throughput sequencing, we identify the activator protein 1 (AP1) as a major partner for productive GR-chromatin interactions. AP1 is critical for GR-regulated transcription and recruitment to co-occupied regulatory elements, illustrating an extensive AP1-GR interaction network. Importantly, the maintenance of baseline chromatin accessibility facilitates GR recruitment and is dependent on AP1 binding. We propose a model in which the basal occupancy of transcription factors acts to prime chromatin and direct inducible transcription factors to select regions in the genome.

Indexed as

Models, GeneticAnimalsBinding SitesCell LineChromatinGene Expression RegulationGenomeLigandsMiceReceptors, GlucocorticoidRegulatory Elements, TranscriptionalTranscription Factor AP-1ChromatinLigandsReceptors, GlucocorticoidTranscription Factor AP-1

Identifiers

PMID21726817
PMCPMC3138120
OpenAlexW1999319214

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.